Wockhardt
Wockhardt Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Wockhardt
Start SIPWockhardt Investment Rating
-
Master Rating:
-
Wockhardt has an operating revenue of Rs. 2,628.00 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of -13% needs improvement, ROE of -6% is poor and needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 80 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 282 | 258 | 241 | 474 |
| Operating Expenses Qtr Cr | 256 | 247 | 236 | 288 |
| Operating Profit Qtr Cr | 26 | 11 | 5 | 186 |
| Depreciation Qtr Cr | 47 | 47 | 47 | 43 |
| Interest Qtr Cr | 52 | 58 | 61 | 78 |
| Tax Qtr Cr | 0 | -40 | -17 | 47 |
| Net Profit Qtr Cr | -55 | -75 | -37 | 40 |
Wockhardt Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 178.6
- 50 Day
- 192.29
- 100 Day
- 207.61
- 200 Day
- 235.22
- 20 Day
- 180.67
- 50 Day
- 194.04
- 100 Day
- 212.78
- 200 Day
- 224.5
Wockhardt Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 173.92 |
| Second Resistance | 176.89 |
| Third Resistance | 178.62 |
| RSI | 24.07 |
| MFI | 26.26 |
| MACD Single Line | -7.06 |
| MACD | -8.02 |
| Support | |
|---|---|
| First Resistance | 169.22 |
| Second Resistance | 167.49 |
| Third Resistance | 164.52 |
Wockhardt Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 2,932,077 | 182,727,039 | 62.32 |
| Week | 1,138,940 | 53,723,809 | 47.17 |
| 1 Month | 676,328 | 30,414,457 | 44.97 |
| 6 Month | 841,485 | 33,869,759 | 40.25 |
Wockhardt Result Highlights
Wockhardt Synopsis
NSE-Medical-Generic Drugs
Wockhardt Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1372.00 Cr. and Equity Capital is Rs. 72.00 Cr. for the Year ended 31/03/2022. Wockhardt Ltd. is a Public Limited Listed company incorporated on 08/07/1999 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1999PLC120720 and registration number is 120720.| Market Cap | 2,321 |
| Sales | 1,255 |
| Shares in Float | 5.76 |
| No of funds | 97 |
| Yield |
| Book Value | 1.05 |
| U/D Vol ratio | 0.7 |
| LTDebt / Equity | 7 |
| Alpha | -0.24 |
| Beta | 1.03 |
Wockhardt
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 60.36% | 63.83% | 65.75% | |
| Mutual Funds | 0.04% | 0.03% | 0.03% | |
| Insurance Companies | ||||
| Foreign Portfolio Investors | 2.87% | 2.98% | 2.81% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 30.26% | 27.42% | 25.97% | |
| Others | 6.47% | 5.74% | 5.44% |
Wockhardt Management
| Name | Designation |
|---|---|
| Dr. Habil Khorakiwala | Founder Chairman |
| Dr. Murtaza Khorakiwala | Managing Director |
| Dr. Huzaifa Khorakiwala | Executive Director |
| Ms. Zahabiya Khorakiwala | Non Executive Director |
| Mr. Aman Mehta | Independent Director |
| Mr. D S Brar | Independent Director |
| Dr. Sanjaya Baru | Independent Director |
| Mrs. Tasneem Mehta | Independent Director |
| Mr. Vinesh Kumar Jairath | Independent Director |
| Mr. Akhilesh Gupta | Independent Director |
| Mrs. Rima Marphatia | Nominee Director |
Wockhardt Forecast
Price Estimates
Wockhardt FAQs
What is Share Price of Wockhardt ?
Wockhardt share price is ₹161 As on 27 March, 2023 | 00:29
What is the Market Cap of Wockhardt ?
The Market Cap of Wockhardt is ₹2320.5 Cr As on 27 March, 2023 | 00:29
What is the P/E ratio of Wockhardt ?
The P/E ratio of Wockhardt is -3.8 As on 27 March, 2023 | 00:29
What is the PB ratio of Wockhardt ?
The PB ratio of Wockhardt is 0.6 As on 27 March, 2023 | 00:29